Trial · NCT00364351
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-Free Survival (PFS) | Vandetanib | 11.3 | Full Range 0.14 to 75.43 | Weeks | |
| Progression-Free Survival (PFS) | Erlotinib | 8.9 | Full Range 0.43 to 80.43 | Weeks | |
| Overall Survival (OS) | Vandetanib | 6.9 | Full Range 0.03 to 18.46 | Months | |
| Overall Survival (OS) | Erlotinib | 7.8 | Full Range 0.10 to 20.04 | Months | |
| Objective Response Rate (ORR) | Vandetanib | 75 | Participants | ||
| Objective Response Rate (ORR) | Erlotinib | 74 | Participants | ||
| Disease Control Rate (DCR) | Vandetanib | 254 | Participants | ||
| Disease Control Rate (DCR) | Erlotinib | 242 | Participants | ||
| Time to Deterioration of Disease-related Symptoms (TDS) by EORTC Quality of Life Questionnaire - Pain | Vandetanib | 11.1 | Inter-Quartile Range 4.4 to 26 | Weeks | |
| Time to Deterioration of Disease-related Symptoms (TDS) by EORTC Quality of Life Questionnaire - Pain | Erlotinib | 9.9 | Inter-Quartile Range 4.3 to 24.3 | Weeks | |
| Time to Deterioration of Disease-related Symptoms (TDS) by EORTC Quality of Life Questionnaire - Dyspnoea | Vandetanib | 12 | Inter-Quartile Range 5.7 to 29.7 | Weeks | |
| Time to Deterioration of Disease-related Symptoms (TDS) by EORTC Quality of Life Questionnaire - Dyspnoea | Erlotinib | 12.4 | Inter-Quartile Range 5.1 to 34.4 | Weeks | |
| Time to Deterioration of Disease-related Symptoms (TDS) by EORTC Quality of Life Questionnaire - Cough | Vandetanib | 15.6 | Inter-Quartile Range 8.1 to 36.1 | Weeks | |
| Time to Deterioration of Disease-related Symptoms (TDS) by EORTC Quality of Life Questionnaire - Cough | Erlotinib | 14.1 | Inter-Quartile Range 7 to 37.6 | Weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00364351/results